EE483 Empagliflozin for Heart Failure Patients Irrespective of Ejection Fraction in Spain: A Cost-Effectiveness Study
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.726
https://www.valueinhealthjournal.com/article/S1098-3015(22)02930-8/fulltext
Title :
EE483 Empagliflozin for Heart Failure Patients Irrespective of Ejection Fraction in Spain: A Cost-Effectiveness Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02930-8&doi=10.1016/j.jval.2022.09.726
First page :
Section Title :
Open access? :
No
Section Order :
10266